LUNDBECK LLC — TTAB Proceedings
LUNDBECK LLC is a party to 8 TTAB proceedings.
Proceedings
- Proceeding 88532787 — Extensions of Time to Oppose, Terminated (filed 2019-12-19) against Safrel Pharmaceuticals as plaintiff
- Proceeding 91243291 — Oppositions, Terminated (filed 2018-08-20) against Novartis AG as plaintiff
- Proceeding 79222202 — Extensions of Time to Oppose, Terminated (filed 2018-06-15) against Novartis AG as plaintiff
- Proceeding 91228273 — Oppositions, Terminated (filed 2016-05-31) against Boehringer Ingelheim International GmbH as plaintiff
- Proceeding 79176276 — Extensions of Time to Oppose, Terminated (filed 2016-03-31) against Boehringer Ingelheim International GmbH as plaintiff
- Proceeding 86600609 — Extensions of Time to Oppose, Terminated (filed 2015-10-20) against Neurodyn Life Sciences Inc. as plaintiff
- Proceeding 91223539 — Oppositions, Terminated (filed 2015-08-28) against Actelion Pharmaceuticals Ltd as plaintiff
- Proceeding 86398901 — Extensions of Time to Oppose, Terminated (filed 2015-03-27) against Actelion Pharmaceuticals Ltd as plaintiff
Marks in These TTAB Matters
Recent Live Filings
- ONFI (CLOBAZAM) CIV — Registered, filed 2023-10-17
- SHAREPLUS — Registered, filed 2023-06-13
- SHARE + PLUS — Registered, filed 2023-06-07
- SABRIL — Registered, filed 2020-03-27
- Trademark 87232905 — Registered, filed 2016-11-10
- ONFI (CLOBAZAM) IV — Registered, filed 2011-04-08
- ONFI (CLOBAZAM) IV — Registered, filed 2011-04-08
- ONFI — Registered, filed 2010-11-02
- SABRIL — Registered, filed 1984-10-12
Common TTAB Counterparties
- Actelion Pharmaceuticals Ltd — 2 proceedings
- Boehringer Ingelheim International GmbH — 2 proceedings
- Novartis AG — 2 proceedings
- Neurodyn Life Sciences Inc. — 1 proceedings
- Safrel Pharmaceuticals — 1 proceedings
Recent TTAB Timeline
- 2020-04-06: 88532787 — TERMINATED involving Safrel Pharmaceuticals
- 2020-01-24: 88532787 — EXTENSION OF TIME GRANTED involving Safrel Pharmaceuticals
- 2020-01-24: 88532787 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Safrel Pharmaceuticals
- 2019-12-19: 88532787 — EXTENSION OF TIME GRANTED involving Safrel Pharmaceuticals
- 2019-12-19: 88532787 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Safrel Pharmaceuticals
- 2019-01-17: 91243291 — TERMINATED involving Novartis AG
- 2019-01-17: 91243291 — BD'S DECISION: DISMISSED W/ PREJUDICE involving Novartis AG
- 2018-12-10: 91243291 — SUBMITTED ON BRIEF involving Novartis AG
- 2018-12-06: 91243291 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2018-12-06: 91243291 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Novartis AG
- 2018-09-27: 91243291 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2018-09-27: 91243291 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Novartis AG
- 2018-08-29: 91243291 — PENDING, INSTITUTED involving Novartis AG
- 2018-08-29: 91243291 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Novartis AG
- 2018-08-20: 91243291 — FILED AND FEE involving Novartis AG
- 2018-06-20: 79222202 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2018-06-15: 79222202 — INCOMING - EXT TIME TO OPPOSE FILED involving Novartis AG
- 2018-03-23: 79222202 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2018-03-22: 79222202 — INCOMING - EXT TIME TO OPPOSE FILED involving Novartis AG
- 2017-03-22: 91228273 — TERMINATED involving Boehringer Ingelheim International GmbH
- 2017-03-22: 91228273 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Boehringer Ingelheim International GmbH
- 2017-02-14: 91228273 — SUBMITTED ON BRIEF involving Boehringer Ingelheim International GmbH
- 2017-02-14: 91228273 — MOT TO AMEND APPLICATION involving Boehringer Ingelheim International GmbH
- 2016-11-21: 91228273 — SUSPENDED involving Boehringer Ingelheim International GmbH
- 2016-11-21: 91228273 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Boehringer Ingelheim International GmbH
- 2016-11-21: 91228273 — TRIAL DATES REMAIN AS SET involving Boehringer Ingelheim International GmbH
- 2016-11-18: 91228273 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Boehringer Ingelheim International GmbH
- 2016-09-13: 91228273 — ANSWER involving Boehringer Ingelheim International GmbH
- 2016-08-31: 91228273 — EXTENSION OF TIME GRANTED involving Boehringer Ingelheim International GmbH
- 2016-07-20: 91228273 — D'S MOTION FOR AN EXTENSION OF TIME involving Boehringer Ingelheim International GmbH